The Series B round was led by N47 with participation from Felicis, Northzone, Gradient, and Italian Founders Fund.
"Every other enterprise software category has been transformed by AI, but the tools managing the world’s largest workforce are still fundamentally the same systems that were built 20 years ago. We had a ten-year plan. AI made it a one-year plan"
Jenson Ventures has backed the property technology startup in its latest funding round to accelerate national scaling.
"Property maintenance sits at the heart of every property management operation, yet it remains one of the last areas to be properly modernised. Having Jenson lead our funding round is a real statement of intent. Their track record of backing ambitious founders at the earliest stage, and the support they bring beyond capital, makes them exactly the right partner as we scale."
The funding round included participation from XTX Ventures and Macmillan Cancer Support to accelerate deployment and expand diagnostics.
"Cancer imaging volumes are rising rapidly but reporting capacity is not keeping pace. Our goal is to give clinicians faster, more confident decisions while reducing unnecessary interventions for patients. With our deep focus on prostate cancer and strong clinical validation across NHS pathways, we’re showing how AI can deliver earlier and more accurate diagnoses. In the NHS, few Trusts can confirm or rule out cancer within 28 days, and some patients can wait two months or longer. Lucida Medical is ideally placed to reduce this burden, and this funding will allow us to do that faster."
The British Business Bank has backed the warehouse robotics provider as part of its recent Series C round.
"The UK consistently produces companies with market-leading technology, which need greater domestic backing to scale globally. The Bank is stepping up to ensure companies like Dexory have the capital they need to innovate and expand here in the UK. We are working with fund managers to create deeper pools of capital and are increasing the scale of our co-investing activity, which directly increases the size of funding rounds for high-potential UK companies."